AstraZeneca plc vs Logitech International SA — how do they compare? AstraZeneca plc trades at $158.09 (market cap $248.14B), while Logitech International SA trades at $103.82 (market cap $14.96B). The key difference: AstraZeneca plc is far larger — about 16.6× Logitech International SA's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | LOGI | |
|---|---|---|
Market Cap | $248.14B | $14.96B |
Sector | Health | Technology |
52-Week High | $209.48 | $126.69 |
52-Week Low | $147.06 | $85.84 |
Enterprise Value | $275.41B | $13.30B |
Dividend Yield | 2.01% | 1.64% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →